Skip to main content

Home/ Groups/ OARS funding Biomed
MiamiOH OARS

PAR-18-263: Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phas... - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to transition the core resources and biomedical research activities of Centers of Biomedical Research Excellence (COBRE) into independence and sustainability.
MiamiOH OARS

PAR-18-254: Increased Knowledge and Innovative Strategies to Reduce HIV Incidence-iKnow... - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to promote innovative research that addresses one or both of the following objectives:
    · Devise optimal strategies to improve the identification of persons unaware of their HIV-1 infection and successfully link them to HIV testing, treatment, and prevention interventions.
    · Develop and examine the feasibility and acceptability of novel integrated interventions of biomedical and behavioral strategies that substantially reduce the likelihood of onward HIV transmission in these populations.
MiamiOH OARS

PAR-18-248: Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessme... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) encourages research project applications under the cooperative agreement (UG3/UH3) mechanism to address the development, optimization and validation of quantitative imaging (QI) software tools and methods for prediction and/or measurement of response to cancer therapies or for planning and validating radiation therapy treatment strategies in clinical trials.



    The scientific scope of this FOA includes:

    · Development and optimization of QI tools and/or methods for treatment planning, predicting or measuring response to therapy as open source tools that will translate into clinical trial decision support;

    · Validation of the optimized tools in clinical settings to demonstrate their value for decision support in ongoing single-site or multi-site clinical trials.



    A phased approach that emphasizes each of these activities must be proposed. Investigators must apply for both the UG3 and UH3 phases together in the single application. The UG3 effort is to be used for the development and optimization of QI tools and methods chosen for study by the investigating team, while the UH3 phase is for the validation of the tools/methods developed in the UG3 phase. The UG3 phase can be no more than 2 years in duration, and the total project cannot exceed 5 years. At completion, UG3 projects will be reviewed by program staff. Those that have met their milestones may be administratively considered by NCI program staff for transition to the UH3 validation phase.
MiamiOH OARS

PAR-18-221: Fast-Track Development of Medications to Treat Cannabis Use Disorders (UG3/... - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the discovery and development of medications to treat Cannabis Use Disorders (CUDs) using the UG3/UH3 mechanism. The objective is to advance medications toward the ultimate goal of obtaining FDA approval. Advances in understanding the cannabinoid systems and the effects of marijuana on the brain, coupled with the availability of both novel and marketed medications that may be efficacious to treat these disorders, offer unprecedented opportunities to develop safe and effective pharmacotherapies for CUDs.
    The compounds to be evaluated can be small molecules or biologics. They can be tested in pre-clinical models and/or for the clinical manifestations of CUDs or their consequences such as withdrawal, craving, or cannabis use relapse. Applications may focus on the development of new chemical entities, new formulations of marketed medications available for other indications, or combinations of medications that hold promise for the treatment of CUDs.
    The UG3/UH3 Phase Innovation Awards Cooperative Agreement involves 2 phases. The UG3 is to support a project with specific milestones to be accomplished by the end of the 2-year period. The UH3 is to provide funding for 3 years to a project that successfully completed the milestones set in the UG3. UG3 projects that have met their milestones will be administratively considered by NIDA and prioritized for transition to the UH3 phase. Investigators responding to this FOA must address both UG3 and UH3 phases.
MiamiOH OARS

PAR-18-217: NICHD Research Education Programs (R25 Clinical Trial Optional) - 0 views

  •  
    The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NICHD R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral and clinical research needs.
    To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development, which are encouraged to include hands-on research experiences.
    This FOA encourages applications to develop and conduct short-term research education programs to improve the knowledge and research skills of biomedical and behavioral scientists conducting research in areas relevant to the mission of NICHD, including reproductive, developmental, behavioral, social, and rehabilitative processes that determine the health and well-being of newborns, infants, children, adults, families, and populations.
MiamiOH OARS

PA-18-398: NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Tri... - 0 views

  •  
    The purpose of the NIH Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented, NIH-supported, independent investigators. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIH research support during this transition in order to help awardees to launch competitive, independent research careers.
    This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary study to an ongoing clinical trial as lead investigator should apply to the companion FOA (PA-18-397).
MiamiOH OARS

PA-18-279: Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Preve... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) encourages implementation research projects designed in partnership with global and domestic service providers, to target the particular needs in the selected community, to achieve the 90/90/90 HIV prevention and treatment targets identified by HIV/AIDS global leadership. The targets for HIV testing are that 90% of all persons living with HIV know their status, for treatment initiation that 90% of those diagnosed receive timely and effective antiretroviral treatment (ART), and for optimal treatment and preventive benefit that 90% of those on treatment achieve sustained viral suppression.



    PA-18-279 uses the R01 grant mechanism while PA-18-280 uses the R21 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism, while applicants with preliminary data and/or include longitudinal analysis may wish to apply using the R01 mechanism.
MiamiOH OARS

PA-18-276: Formative and Pilot Intervention Research for Prevention and Treatment of HI... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention or treatment. For the purposes of this FOA, "intervention" is defined to include behavioral, social, or structural approaches, as well as combination biomedical and behavioral, social, or structural approaches that prevent acquisition and transmission of HIV infection, or improve clinical outcomes for persons who are HIV infected, or both.
MiamiOH OARS

PA-18-274: Innovations in Mechanisms and Interventions to Address Mental Health in HIV ... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) encourages applications focused on

    1) advancing understanding of mechanisms by which mental health affects HIV prevention and treatment in order to identify modifiable intervention targets; and

    2) developing and testing expanded interventions to improve both mental health and HIV outcomes along the entire HIV care continuum (from HIV testing to viral suppression
    PA-18-274 uses the R01 grant mechanism while PA-18-275 uses the R21 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism, while applicants with preliminary data and/or include longitudinal analysis may wish to apply using the R01 mechanism.
MiamiOH OARS

PA-18-271: Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) encourages innovative, targeted basic behavioral and social science and intervention development research to reduce incident HIV infections and improve the health of those living with HIV. This FOA encourages research designed to

    (a) conduct basic behavioral and social science research that is needed to advance the development of HIV prevention and care interventions,

    (b) translate and operationalize the findings from these basic studies to develop interventions and assess their acceptability and feasibility and

    (c) conduct tests of the efficacy of HIV prevention and care interventions



    PA-18-273 uses the R01 grant mechanism while this FOA uses the R21 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism, while applicants with preliminary data and/or include longitudinal analysis may wish to apply using the R01 mechanism.
MiamiOH OARS

CURE Epilepsy - 0 views

  •  
    The Taking Flight Award seeks to promote the careers of young epilepsy investigators, enabling them to develop a research focus independent of their mentor(s).
    In 2018, CURE will issue one request for proposals for the Taking Flight Award. Please refer to the LOI guidelines for an overview of CURE's 2018 priority areas, application instructions and FAQs.
    Eligibility
    You must fall into one of the following categories to be eligible for the Taking Flight Award:
    A senior postdoctoral fellow who has a minimum of 3 years postdoctoral experience
    A clinical fellow who is a Neurology Resident in his/her Neurology training and considering Epilepsy Fellowships
    Newly appointed faculty within one year of having completed postdoctoral training
MiamiOH OARS

Miami University - M.I.A.M.I WOMEN Grant application - 0 views

  •  
    Applicants for the funds may be students or faculty. The project, program, or entrepreneurial idea must be created by, led by or benefit women.

    Grants are awarded in values of $2500 to $20,000. While we prefer the base grant to be $5,000, we are considering a limited number of $2500 which will be required to show high impact. These applicants will be considered on a case-by-case basis.

    The grants must be submitted online via the link below and must include a 2-minute video. Applicants will be narrowed to a pool of 10-15 finalists by our M.I.A.M.I. WOMEN Grants Committee. This committee will review applications; contact applicants if additional information is required, and present the finalists to the M.I.A.M.I. WOMEN Steering Committee and Development Staff.

    Grant deadline for this year is Feb. 9, 2018.

    These finalists will perform in a fast-pitch style Hawk Tank event on April 11, 2018. Finalists will be offered fast-pitch training courtesy of the Farmers School of Business - school of Entrepreneurship, and will receive coaching and support. They will then pitch their idea in 5 minutes or less on April 11, 2018 at the event. Giving Circle members are the voters who will determine winners. Absentee voters will be given the option to vote online.

    Winners will be announced that night or the next day at the Symposium, to be determined.
MiamiOH OARS

Medical Research Fellows Program | HHMI.org - 0 views

  •  
    The Medical Research Fellows Program enables students to be immersed in a high-impact, intensive research experience at a critical time in their professional education, before they make plans for residency or postdoctoral training. Unique aspects of the program include national and regional professional development activities, mentorship by physician-scientists, interaction with HHMI investigators, and integration into a community of like-minded peers.

    Each student selects and works with a mentor to develop a basic, translational, or applied biomedical research proposal. Both mentor selection and the research proposal are key components of the fellowship application; working with an HHMI scientist is encouraged but not required. Mentors can be at any academic or nonprofit research institution in the United States (excluding the National Institutes of Health and any other government agency) or at HHMI's Janelia Research Campus in Ashburn, VA. 
MiamiOH OARS

T1 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical ... - 0 views

  •  
    The involvement of small businesses in translational aging research could substantially hasten the pace at which scientific advances are transformed into commercial products to improve or maintain the health and functional independence of older adults. Therefore, this funding opportunity announcement (FOA) is intended to encourage a greater involvement by small businesses through the SBIR mechanism in transforming scientific advances in aging research into novel devices, products, health care practices and programs that will benefit the lives of older adults.
    For the purposes of this FOA, T1 translational research on aging is defined as the application of basic and clinical biomedical or basic behavioral and social research findings towards the development of new strategies for prevention and treatment of age-related pathologies. T1 translational research approaches could include the development of new research tools or improving existing technologies to diagnose, prevent or treat age-related conditions, functional decline and disability.
MiamiOH OARS

Epidemiology and Prevention in Alcohol Research (R01 - Clinical Trial Optional) - 0 views

  •  
    This Funding Opportunity Announcement (FOA) encourages the submission of investigator-initiated research grant applications to support research investigating the epidemiology of alcohol use, alcohol-related harms, and alcohol use disorders and the prevention of underage drinking, alcohol-related harms, and alcohol use disorders.
MiamiOH OARS

The Esther A. & and Joseph Klingenstein Fund, Inc. - 0 views

  •  
    The Esther A. & Joseph Klingenstein Fund, in partnership with the Simons Foundation, has announced the opening of its 2018 competition for research fellowships in the neurosciences.
    Previously known as the Klingenstein Fellowship Awards in the Neurosciences, this year's awards are the second from this joint initiative. The awards are presented to highly promising early-career scientists. At a critical juncture in young investigators' careers when funding can be a challenge, the awards are intended to promote higher-risk, and potentially higher-reward, projects.
    Payable over three years, the $225,000 award may be used for salary support, research assistants, equipment, or any other purpose that promotes the scientific activities of the fellow.
    To be eligible, investigators must hold a PhD and/or MD degree and have completed all their research training, including postdoctoral training. In addition, the applicant must be an independent investigator within four years (between July 1, 2014, and July 1, 2018) of receiving his/her first tenure-track appointment at a university or medical institution.
MiamiOH OARS

American Liver Foundation Seeks Applications for 2018 Research and Fellowship Awards | ... - 0 views

  •  
    1) Liver Scholar Awards: Three-year grants of up to $225,000 will be awarded in support of basic science research projects. The goal of the program is to provide young scientists with support at an early stage of their careers to bridge the gap between completion of their research training and attainment of status as an independent research scientist. While applications on all liver-related research topics will be considered, preference will be given to projects related to biliary atresia and primary biliary cirrhosis.

    2) Postdoctoral Research Fellowship Award: One-year grants of up to $12,500 will be awarded to support MD, PhD, and MD/PhD postdoctoral fellows in their first or second year of appointment as a postdoctoral research fellow or trainee and who seek professional development, additional training, and experience in liver research. The foundation encourages projects related to transplantation, autoimmune hepatitis, hepatitis, primary sclerosing cholangitis, biliary atresia, and primary biliary cirrhosis.

    3) Primary Biliary Cholangitis (PBC) Fund for the Cure Award: The PBC Fund for the Cure Award is a one-year award of $100,000 that provides support for a faculty member to initiate a project that addresses a novel and important research question related to the process by which primary biliary cholangitis attacks the liver. The proposed investigation may involve basic, clinical, or translational research. The award supports investigational work related but not limited to pathophysiological studies, clinical trials and applications, or assessment of new diagnostic and/or therapeutic modalities.
MiamiOH OARS

National Psoriasis Foundation Issues RFP for Discovery Grant | RFPs | PND - 0 views

  •  
    Grants of up to $75,000 will be awarded to support researchers as they explore preliminary ideas and conduct proof-of-concept experiments. The goal of the program is to stimulate the development of new research programs in the field of psoriatic disease that are capable of competing for long-term funding from the National Institutes of Health or other agencies in the future. Researchers with a specific focus on psoriatic arthritis, public health, and co-morbidities are strongly encouraged to apply.
MiamiOH OARS

PA-18-385: Population Health Interventions: Integrating Individual and Group Level Evid... - 0 views

  •  
    To improve health and reduce the burden of disease, scientific research needs to be implemented at the population level in addition to the biological and clinical levels. The purpose of this funding opportunity announcement (FOA) is to support multilevel, transdisciplinary population health interventions that target underlying social, economic, and environmental conditions in an effort to improve health outcomes.

MiamiOH OARS

PA-18-396: Mentored Quantitative Research Development Award (Parent K25 - No Independen... - 0 views

  •  
    The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease.  The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research.

‹ Previous 21 - 40 of 1868 Next › Last »
Showing 20 items per page